Aligos Therapeutics, Inc. financial statements
Aligos Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 2.19M | 10-K |
| Net income | −USD 24.19M | 10-K |
| Cash and equivalents | USD 18.3M | 10-Q |
| Total debt | USD 5.25M | EODHD |
Aligos Therapeutics, Inc. financials on 6ix · Aligos Therapeutics, Inc. on 6ix